Target intelligence / Profile preview

Angiogenic factor with G-patch and FHA domains 1 pseudogene 3 (AGGF1P3)

Target
AGGF1P3
Molecular classification
Pseudogene, Processed pseudogene, Retrogene
01

Overview

AGGF1P3 is a processed pseudogene located on chromosome 16, derived from the parent gene AGGF1. Unlike active genes, processed pseudogenes like AGGF1P3 are formed through retrotransposition and lack introns, making them typically nonfunctional and incapable of producing protein products. While some pseudogenes can influence biological processes via RNA-mediated regulation of their parent genes, AGGF1P3 itself is not documented to have such a function and is not considered a therapeutic target. In summary, AGGF1P3 is not a conventional biomedical target; it is a noncoding pseudogene with no established role as a receptor, enzyme, transporter, or drug target. If structured information or research intended to focus on gene targets for therapy or diagnostics, AGGF1P3 should be excluded or flagged as non-relevant.

02

Mechanism of action

None known; pseudogenes rarely have direct mechanisms of action in drug response.

03

Biological functions

No direct biological functions; pseudogenes generally do not encode functional proteins. In rare cases, they can regulate parent gene expression via RNA mechanisms but no documented evidence for AGGF1P3 specifically.
04

Disease associations

None established for AGGF1P3 specifically; pseudogenes in general may influence disease through regulatory RNA, but no direct link for AGGF1P3 is reported.

Beyond the preview

Go deeper on Angiogenic factor with G-patch and FHA domains 1 pseudogene 3 (AGGF1P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Angiogenic factor with G-patch and FHA domains 1 pseudogene 3 (AGGF1P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call